HIV-1-related central nervous system diseases

Current Opinion in Neurology

Volumn 12, Issue 4, 1999, Pages 377-381

  Tardieu, Marc ^a,b  

^a BICÊTRE HOSPITAL   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT;

CELL ACTIVATION; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; DEMENTIA; GLIA CELL; HEREDITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; REVIEW; VIRUS LOAD;

AIDS DEMENTIA COMPLEX; BLOOD-BRAIN BARRIER; BRAIN; GENETIC PREDISPOSITION TO DISEASE; HUMANS;

EID: 0033396290     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-199908000-00002     Document Type: Review

References (39)

1. Zheng J, Gendelman HO. The HIV-1 associated dementia complex: a metabolic encephalopathy fueled by viral replication in mononuclear phagocytes. Curr Opin Neurol 1997; 10:319-325.
2. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, et al. Dementia in AIDS patients incidence and risk factors. Neurology 1993; 43:2245-2252.
3. Tardieu M, Le Chenadec J, Persoz A, Meyer L, Blanche S, Mayaux MJ, et al. HIV-1 related encephalopathy in infants, children and adults. 1999 (submitted).
4. Tardieu M, Mayaux MJ, Seibel N, Funck-Brentano I, Straub E, Teglas JP, et al. Cognitive assessment of school-age children infected with maternally transmitted human immunodeficiency virus type 1. J Pediatr 1995; 126:375-379.
5. + patients. Neurology 1999; 52:995-1003.
6. Simone IL, Federico F, Tortorella C, Andreula CF, Zimatore GB, Giannini P, et al. Localised H-1-MR spectroscopy for metabolic characterisation of diffuse and focal brain lesions in patients infected with HIV. J Neurol Neurosurg Psychiatry 1998; 4:516-523.
7. 3. AIDS-associated dementia, however, was not directly evaluated.
8. Brodt HR, Kamps PS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997; 11:1731-1738.
9. Costagliola D. Conséquences de l'utilisation des traitements antirétroviraux puissants sur l'épidémiologie des manifestations cliniques de l'infection à VIH [in French]. Méd Thér 1999; 5:64-70. This very large study is published in French.
10. Ferrando S, van Gorp W, McElhiney M, Goggin K, Sewell M, Rabkin J. Highly active antiretroviral treatment in HIV infection: benefits for neuropsychological function. AIDS 1998; 12:F65-F70.
11. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis 1997; 175:963-966.
12. Ellis RJ, Hsia K, Spector SA, Nelson JA, Heaton RK, Wellace MR, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol 1997; 42:679-688.
13. McArthur JC, McClernon DR, Cronin MF, Nance-Sposon TE, Saah AJ, St Clair M, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol 1997; 42:689-698.
14. Cinque P, Vago L, Ceresa D, Minini F, Terreni MR, Vagani A, et al. Cerebrospinal fluid HIV-1 RNA levels: correlation with HI encephalitis. AIDS 1998; 12:389-394.
15. Monno L, Di Stefano M, Zimatore GB, Andreula CF, Appice A, Perulli LM, et al. Measurement of viral sequences in cerebrospinal fluid of AIDS patients with cerebral white-matter lesions using polymerase chain reaction. AIDS 1998; 12:581-590.
16. Childs EA, Lyles RS, Seines OA, Chen B, Miller EN, Cohen BA, et al. Plasma viral load and Cd4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology 1999; 52:607-613.
17. Foudraine NA, Hoetelmans RMW, Lange JMA, de Wolf F, van Benthem BHB, Maas JJ, et al. Cerebrospinal-fluid HIV-1 RNA and drug concentrations after treatment with lamivudine plus zidovudine or stavudine. Lancet 1998; 351:1547-1551.
18. Bouwman FG, Skolasky RL, Hes D, Seines OA, Glass JD, Nance-Sproson TE, et al. Variable progression of HIV-associated dementia. Neurology 1998; 50:1814-1820.
19. Masliah E, Heaton RK, Marcotte TD, Ellis RJ, Wiley CA, Mallory M, et al. Dendritic injury is a pathologicl substrate for human immunodeficiency virus-related cognitive disorders. Ann Neurol 1997; 6:963-972.
20. Giometto B, An SF, Groves M, Scaravilli T, Geddes JF, Miller R, et al. Accumulation of β-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities. Ann Neurol 1997; 42:34-40.
21. Adle-Biassette H, Chretien F, Wingertsmann L, Hery C, Ereau T, Scaravilli F et al Neuronal apoptosis does not correlate with dementia in HIV infection but is related to microglial activation and axonal damage. Neuropathol Appl Neurobiol 1999; 25:123-133.
22. Janabi N, Di Stefano M, Wallon C, Héry C, Chiodi F, Tardieu M. Induction of human immunodeficiency virus type 1 replication in human glial cells after proinflammatory cytokines stimulation: effect of IFNγ, IL1β, and TNFα on differentiation and chemokine production in glial cells. Glia 1998; 23:304-315.
23. Conant K, Garzinodemo A, Nath A, McArthur JC, Halliday W, Power C, et al. Induction of monocyte chemoattractant protein-1 in HIV-1 Tat-stimulated astrocytes and elevation in AIDS dementia. Proc Natl Acad Sci USA 1998; 6:3117-3121.
24. 2-) regulatory pathways. J Immunol 1996; 157:2129-2135.
25. Adamson DC, Wildemann B, Sasaki M, Glass JD, McArthur JC, Christov VI, et al. Immunologic NO synthase: elevation in severe AIDS dementia and induction by HIV-1 gp41. Science 1996; 274:1917-1921.
26. Vincent VAM, De Groot CJA, Lucassen PJ, Portegies P, Troost D, Tilders FJH, et al. Nitric oxide synthase expression and apoptotic cell death in brains of AIDS and AIDS dementia patients. AIDS 1999; 13:317-326.
27. Boven LA, Gomes L, Héry C, Gray F, Verhoef J, Portegies P, et al. Increased peroxynitrite activity in AIDS dementia complex: implications for the neuropathogenesis of HIV-1 infection. J Immunol 1999; 162:4319-4327. This paper presents a direct demonstration of the role of free radicals and peroxinitrite in AIDS-related dementia and of the relation between viral infection of activated microglial cells or monocytes and the production of superoxide anion.
28. Vitkovic L, Tardieu M. Neuropathogenesis of HIV-1 infection. Outstanding questions. CR Acad Sci Paris Sci de la Vie 1998; 321:1015-1021. This paper is just another review by the present author (in collaboration) but it is a good complement to the present review and more biology orientated.
29. Magierowska M, Theodorou I, Debré P, Sanson F, Autran B, Rivière Y, et al. Combined genotypes of CCR5, CCR2, SDF1, and HLA genes can predict the long-term nonprogressor status in human immunodeficiency virus-1-infected individuals. Blood 1999; 3:936-941. This is not the first study on the subject, but has a very comprehensive approach to testing CCR5, CCR2, SDF-1 and HLA genes in parallel in a large cohort.
30. Glabinski AR, Ransohoff RM. Chemokines and chemoline receptors in CNS pathology. J Neurovirol 1999; 5:3-12.
31. Sanders VJ, Pittman C, White MG, Wang G, Wiley CA, Achim CL. Chemokines and receptors in HIV encephalitis. AIDS 1998; 12:1021-1026.
32. Vallat AV, De Girolami U, He J, Mhashilkar A, Marasco W, Shi B, et al. Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 1998; 152:167-178.
33. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, et al. Role for neuronally derived fraktalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A 1998; 95:10896-10901.
34. Barroga CF, Ellis R, Nelson J, Heton RK, Atkinson JH, McCutchan JA, et al. Correspondence.HIV-1 neurocognitive disorders and chemokine receptors. AIDS 1997; 11:1651-1664.
35. Corder EH, Robertson K, Lannfelt L, Bogdanovic N, Eggertsen G, Wilkins J, et al. HIV-inected subjects with the E4 allele for APOE have excess dementia and peripheral neuropathy. Nature Med 1998; 10:1182-1184. This paper reports an intriguing finding. It was obtained, however, from a small group of patients.
36. Enting RH, Hoetelmans MW, Lange JMA, Burger DM, Beijnen JH, Portegies P. Antiretroviral drugs and the central nervoux system. AIDS 1998; 12:1941-1955.
37. The Dana Consortium on the therapy of HIV dementia and related cognitive disorders. A randomized, double-blind, placebo-controlled trial of deprenyl and thioctic acid in human immunodeficiency virus-associated cognitive impairment. Neurology 1998; 50:645-651.
38. Heseltine PNR, Goodkin K, Atkinson JH, Vitiello B, Rochon J, Eaton EM, et al. Randomized double-blind placebo-controlled trial of peptide T for HIV-associated cognitive impairment. Arch Neurol 1998; 1:41-51.
39. Navia BA, Dafni U, Simpson D, Tucker T, Singer E, McArthur JC, et al. A phase I/II trial of nimodipine for HIV-related neurologic complications. Neurology 1998; 51:221-228.